Is Peripheral Artery Disease Linked to Inflammation?
Peripheral artery disease narrows the arteries that carry blood to the legs, and a large body of research places inflammation at the heart of how it develops, worsens, and signals danger elsewhere in the body.
Written by Sydney Murphy, CMO & Digital Products Officer. Reviewed by the Sensa Wellness editorial team. Written to reflect current, publicly available inflammation research.
Yes. Peripheral artery disease (PAD) is a form of atherosclerosis in the arteries of the legs, and inflammation runs through how it develops and progresses. People with higher levels of inflammatory markers such as C-reactive protein (CRP) are more likely to develop PAD, tend to have more severe disease, and face a higher risk of heart attack, stroke, and limb complications. Inflammation is not the only cause, but it is one of the most consistently documented drivers, and one you can measure and influence.
Peripheral artery disease is a condition in which fatty, fibrous plaque builds up inside the arteries that supply the legs and feet, narrowing them and limiting blood flow. The classic symptom is intermittent claudication: a cramping ache in the calves or thighs that appears during walking and eases with rest. In more advanced disease, poor circulation can cause pain at rest, slow-healing wounds, and, in severe cases, tissue loss. PAD affects a large share of older adults and is strongly tied to smoking, diabetes, and age.
For a long time, PAD was framed mainly as a plumbing problem: pipes clogged by cholesterol. That picture is incomplete. Atherosclerosis, the underlying process, is now understood as an inflammatory disease of the artery wall, and PAD is one of its most telling manifestations. The question is not just whether inflammation and PAD occur together, but whether inflammation helps cause PAD and whether measuring it tells you anything useful. On both counts, the research is substantial.
| Aspect | What the inflammation connection looks like |
|---|---|
| Developing PAD | Higher baseline CRP in healthy people predicts a greater chance of later developing symptomatic PAD. |
| Disease severity | Inflammatory markers tend to rise as PAD becomes more severe and as walking ability declines. |
| Outcomes after treatment | Elevated CRP before leg revascularization predicts more cardiovascular events and limb complications afterward. |
| Whole-body risk | Because PAD reflects systemic atherosclerosis, inflammation in the legs also flags heart and brain risk. |
What the Research Actually Shows
The link between inflammation and PAD is one of the better-replicated findings in vascular medicine, built on large prospective cohorts of initially healthy people followed for years.
Inflammation predicts who develops PAD. The landmark evidence comes from the Physicians' Health Study. Among apparently healthy men, baseline CRP measured years before any symptoms predicted who would go on to develop PAD. The risk rose with each quartile of CRP, and men in the highest quartile had roughly twice the risk of developing symptomatic PAD compared with those in the lowest, with relative risks across quartiles of 1.0, 1.3, 2.0, and 2.1. For the men who eventually needed surgical revascularization, the gradient was even steeper, reaching a relative risk of about 4.1 in the highest quartile, and the association held after accounting for cholesterol, blood pressure, diabetes, and family history (Ridker et al., Circulation, 1998). This was among the first evidence that inflammation precedes PAD rather than simply accompanying it.
CRP outperforms many traditional markers. A later analysis within a cohort of 14,916 initially healthy male physicians compared eleven different blood markers as predictors of future PAD. Of all the non-lipid markers tested, CRP was the strongest, with men in the highest quartile facing a relative risk of 2.8 (95 percent confidence interval 1.3 to 5.9) compared with the lowest, and adding CRP to standard cholesterol screening meaningfully improved the ability to predict who would develop the disease (Ridker et al., JAMA, 2001). In other words, inflammation carried prognostic information that cholesterol alone missed.
How Inflammation Drives the Disease
The association is strong, but mechanism is what turns a correlation into a plausible cause. Researchers have mapped several ways inflammation physically shapes the atherosclerosis that underlies PAD.
It injures the artery lining. Atherosclerosis begins with damage to the endothelium, the thin layer of cells lining blood vessels. Inflammatory signaling makes this lining stickier, so circulating immune cells latch on and migrate into the vessel wall. Once inside, these cells engulf cholesterol and become the foam cells that form the fatty core of a plaque. This is as true in the leg arteries as in the heart.
It builds and destabilizes plaque. Inflammatory cytokines keep immune cells active inside the growing plaque, driving its expansion and weakening the fibrous cap that holds it together. A plaque with a thin, inflamed cap is more likely to rupture, triggering a clot that can abruptly block an already narrowed artery. In the legs, that can turn stable claudication into a sudden, limb-threatening event.
It feeds a self-reinforcing loop. Reduced blood flow and the repeated cycles of oxygen starvation and reperfusion that occur in PAD muscles generate oxidative stress, which in turn stokes more inflammation. Poor circulation also impairs wound healing and raises infection risk, both of which add to the inflammatory load. This overlap is part of why conditions that raise inflammation, from diabetes to smoking to obesity, are also the dominant risk factors for PAD.
Beyond CRP, other signals point the same way. Interleukin-6 (IL-6), an upstream cytokine that drives the liver to produce CRP, has itself been tied to higher PAD risk across many studies, independent of CRP, strengthening the case that inflammatory signaling is an active participant rather than a passive bystander (Mehta et al., Current Atherosclerosis Reports, 2024).
Inflammation, Severity, and What Happens Next
Inflammation is not only linked to whether PAD develops. It also tracks with how bad the disease is and how people fare over time.
Reviews of the clinical literature have found that CRP levels tend to correlate with the severity of PAD and with the likelihood of future cardiovascular events, which is why inflammatory markers have been studied as tools to refine risk beyond the ankle-brachial index alone (Stone and Yacoub, Seminars in Vascular Surgery, 2015). The pattern carries through to people who undergo procedures to restore blood flow. In a study of patients having angioplasty or stenting for leg arteries, those with elevated high-sensitivity CRP beforehand were more likely to suffer a major adverse cardiovascular event within two years, with a hazard ratio of 2.9 (95 percent confidence interval 1.1 to 7.6); patients who had both high CRP and a high level of the cardiac marker BNP were more than ten times as likely to experience such an event as those with normal levels of both (Stone et al., Journal of Vascular Surgery, 2014). The inflammatory state of the body before treatment appears to shape what happens after it.
Why PAD Rarely Travels Alone
Here is the point that often surprises people: peripheral artery disease is, in an important sense, not just a leg problem. It is a visible sign of atherosclerosis happening throughout the body. The same inflamed, plaque-laden process that narrows a leg artery is almost always at work in the coronary arteries of the heart and the carotid arteries feeding the brain. This is why a PAD diagnosis carries a markedly elevated risk of heart attack and stroke, often higher than the risk to the legs themselves.
Inflammation is one of the threads that connects these territories. A raised CRP in someone with leg symptoms is not just describing their calves; it reflects a systemic inflammatory and atherosclerotic burden that affects multiple vascular beds at once. That is part of why cardiologists and vascular specialists treat PAD as a whole-body cardiovascular condition, not a localized nuisance, and why managing it means addressing the same risk factors that protect the heart.
What This Means If You Are Thinking About Your Own Risk
It is important to be precise about what the research supports. Elevated inflammation is a risk marker and a contributing factor for PAD, not a diagnosis, and a normal CRP does not rule out arterial disease. PAD is diagnosed with a physical exam and tests such as the ankle-brachial index or imaging, not with a single blood marker. Many people develop PAD primarily through smoking, diabetes, or age, and CRP is a general wellness marker rather than a screening test for blocked arteries.
What inflammation does offer is a modifiable lever. The same lifestyle factors that lower chronic inflammation are also the ones most consistently linked to lower PAD risk and better outcomes in people who already have it.
- Stopping smoking: Tobacco is the single most powerful driver of PAD and a potent source of vascular inflammation. Quitting lowers both, and it is the most impactful change most people can make.
- Managing blood sugar: Diabetes accelerates inflammatory damage to small and large arteries alike, and good glucose control eases that pressure.
- Moving more: Supervised walking programs improve symptoms in PAD, and regular activity lowers baseline inflammation throughout the body.
- Diet and weight: An eating pattern rich in vegetables, fruit, whole grains, and healthy fats is associated with lower inflammatory markers, while excess visceral fat secretes inflammatory signals of its own.
Where Tracking CRP Fits In
Because inflammation is one of the threads connecting PAD to its risk factors and its outcomes, CRP offers a window into that underlying state. It will not tell you whether a leg artery is narrowed at any given moment, and it is not a substitute for an ankle-brachial index, imaging, or a vascular specialist. What it can do is reflect the chronic inflammatory load that the research links to atherosclerosis, and show whether that load is trending up or down as you make changes.
C-reactive protein is the most practical marker for this because it reflects the same IL-6-driven inflammatory signaling implicated in plaque formation, and it responds within days to weeks to real change. Sensa is designed to make checking it simple, letting you measure CRP at home without a needle or a clinic visit, so a reading becomes a routine data point rather than a rare event. For someone working to protect their circulation, watching CRP drift downward as they quit smoking, control blood sugar, or build a walking habit is a tangible signal that the inflammatory pressure on their arteries is easing. CRP is a general wellness marker rather than a diagnosis, so persistent elevations, and any symptoms such as leg pain with walking, non-healing sores, or coldness in a limb, are worth discussing with a healthcare provider.
The bottom line is that inflammation is not the whole story of peripheral artery disease, but it is a central and well-documented part of it, and unlike age or family history, it is something you can measure and influence.
Sources
- Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97(5):425-428. pubmed.ncbi.nlm.nih.gov/9490235
- Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285(19):2481-2485. pubmed.ncbi.nlm.nih.gov/11368701
- Stone PA, Schlarb H, Campbell JE, et al. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization. Journal of Vascular Surgery. 2014;60(3):652-660. pubmed.ncbi.nlm.nih.gov/24795153
- Stone PA, Yacoub M. Inflammatory biomarkers in peripheral arterial disease. Seminars in Vascular Surgery. 2015;27(3-4):148-151. pubmed.ncbi.nlm.nih.gov/26073823
- Mehta NN, deGoma E, Shapiro MD. IL-6 and Cardiovascular Risk: A Narrative Review. Current Atherosclerosis Reports. 2024;27(1):12. pubmed.ncbi.nlm.nih.gov/39589436
Frequently Asked Questions
Is peripheral artery disease caused by inflammation?
Peripheral artery disease is caused by atherosclerosis, the buildup of plaque in the arteries, and that process is now understood as fundamentally inflammatory. Inflammation injures the artery lining, helps build and destabilize plaque, and tends to rise as the disease worsens. It is one of several contributing factors rather than the sole cause, alongside major drivers like smoking, diabetes, and age, but research consistently shows that higher inflammatory markers predict a greater risk of developing PAD.
Can a high CRP level mean I have PAD?
No. A high CRP reflects general inflammation in the body and is not a diagnosis of peripheral artery disease or any blocked artery. It signals elevated cardiovascular risk worth paying attention to, but PAD is diagnosed with tests such as the ankle-brachial index or imaging. If you have leg pain when walking, non-healing sores on the feet, or a limb that feels cold or looks pale, see a healthcare provider regardless of your CRP level.
Why is peripheral artery disease considered a whole-body condition?
PAD is a sign that atherosclerosis is affecting arteries beyond the legs. The same inflamed, plaque-forming process almost always involves the coronary arteries of the heart and the carotid arteries supplying the brain, which is why a PAD diagnosis carries a high risk of heart attack and stroke. An elevated inflammatory marker in someone with leg symptoms reflects a systemic burden, not just a local one.
Can lowering inflammation help with PAD risk?
The lifestyle changes that lower chronic inflammation, especially stopping smoking, controlling blood sugar, staying physically active, and eating an anti-inflammatory diet, are also the changes most consistently linked to lower PAD risk and better outcomes. Many appear to work partly by easing the inflammatory load on the arteries. These steps support general cardiovascular wellness but are not a treatment for diagnosed PAD, which requires medical care.
Want to track your inflammation as part of a healthy lifestyle?
Sensa is a general wellness tool that lets you measure your CRP levels at home. No needles, no clinic visit. Track trends over time and make more informed lifestyle choices.
Buy Now